HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

poly(glycerol adipate-co-omega-pentadecalactone)

Also Known As:

PGA-co-PDL

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Macromolecular Substances: 97
- Polymers: 13051
  - Polyesters: 921
    - poly(glycerol adipate-co-omega-pentadecalactone): 3
Biomedical and Dental Materials
- Polymers: 13051
  - Polyesters: 921
    - poly(glycerol adipate-co-omega-pentadecalactone): 3
Technology, Industry, and Agriculture
- Manufactured Materials
  - Biomedical and Dental Materials
    - Polymers: 13051
      - Polyesters: 921
        poly(glycerol adipate-co-omega-pentadecalactone): 3

Experts

1.	Hutcheon, Gillian A: 3 articles (10/2019 - 01/2013)
2.	Saleem, Imran Y: 3 articles (10/2019 - 01/2013)
3.	Mohamed, Adel: 2 articles (10/2019 - 03/2019)
4.	Ross, Kehinde: 2 articles (10/2019 - 03/2019)
5.	Pekoz, Ayca Y: 1 article (10/2019)
6.	Kunda, Nitesh K: 1 article (03/2019)
7.	Evans, Andrew R: 1 article (01/2013)
8.	Iftikhar, Abid: 1 article (01/2013)
9.	Mohammed, Afzal R: 1 article (01/2013)
10.	Shabir, Anjum: 1 article (01/2013)

Related Diseases

1.	Chronic Obstructive Pulmonary Disease (COPD) 10/05/2019 - "These results indicate the optimal process parameters for the preparation of NCMPs of miR-146a-containing PGA-co-PDL NPs suitable for inhalation in the treatment and management of COPD." 03/01/2019 - "Therefore, these results demonstrate the potential of PGA-co-PDL NPs as a delivery system for miR-146a to treat COPD."
2.	Lung Diseases (Lung Disease) 01/30/2013 - "The results indicate PEG-co-(PGA-co-PDL) can be considered as a potential biodegradable polymer carrier for dry powder inhalation of macromolecules for treatment of local pulmonary diseases."

Related Drugs and Biologics

1.	Powders
2.	Polymers